Dynamic multi-bed FDG PET imaging: Feasibility and optimization

IEEE Nuclear Science Symposium Conference Record

Volumn , Issue , 2011, Pages 3863-3870

  Karakatsanis, Nicolas A ^a   Lodge, Martin A ^a   Zhou, Yun ^a   Mhlanga, Joyce ^a   Chaudhry, Muhammad A ^a   Tahari, Abdel K ^a   Segars, William P ^b   Wahl, Richard L ^a   Rahmim, Arman ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA ACQUISITION; HOSPITAL DATA PROCESSING; IMAGE SEGMENTATION; INTELLIGENT SYSTEMS; MONTE CARLO METHODS; PATIENT TREATMENT; PHOSPHORYLATION;

CLINICAL FEASIBILITY; METASTATIC DISEASE; MONITORING CAPABILITIES; REGION OF INTEREST; STANDARDIZED UPTAKE VALUES; TRACER KINETIC MODELING; TREATMENT RESPONSE; WHOLE-BODY IMAGING;

MEDICAL IMAGING;

EID: 84863338160     PISSN: 10957863     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/NSSMIC.2011.6153735     Document Type: Conference Paper

References (36)

1. R. Wahl and J. Buchanan, Principles and practice of positron emission tomography. Lippincott Williams & Wilkins, 2002.
2. F. Castell and G. Cook, "Quantitative techniques in 18-FDG PET scanning in oncology," British Journal of Cancer, vol. 98, no. 10, pp. 1597-1601, 2008. (Pubitemid 351684676)
3. K. Facey, I. Bradbury, G. Laking, and E. Payne, Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Gray on behalf of the National Coordinating Centre for Health Technology Assessment, 2007.
4. M. Dahlbom, E. Hoffman, C. Hoh, C. Schiepers, G. Rosenqvist, R. Hawkins, M. Phelps et al., "Whole-body positron emission tomography: Part i. methods and performance characteristics." Journal of Nuclear Medicine, vol. 33, no. 6, p. 1191, 1992.
5. R. Hustinx, F. Bénard, and A. Alavi, "Whole-body FDG-PET imaging in the management of patients with cancer*," in Seminars in nuclear medicine, vol. 32, no. 1. Elsevier, 2002, pp. 35-46.
6. K. Kubota, M. Itoh, K. Ozaki, S. Ono, M. Tashiro, K. Yamaguchi, T. Akaizawa, K. Yamada, and H. Fukuda, "Advantage of delayed whole-body FDG-PET imaging for tumour detection," European Journal of Nuclear Medicine and Molecular Imaging, vol. 28, no. 6, pp. 696-703, 2001.
7. D. Townsend, "Positron emission tomography/computed tomography,"in Seminars in nuclear medicine, vol. 38, no. 3. Elsevier, 2008, pp. 152-166.
8. N. Sadato, T. Tsuchida, S. Nakaumra, A. Waki, H. Uematsu, N. Takahashi, N. Hayashi, Y. Yonekura, and Y. Ishii, "Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours," European Journal of Nuclear Medicine and Molecular Imaging, vol. 25, no. 6, pp. 559-564, 1998. (Pubitemid 28297829)
9. W. Wong and K. Hicks, "A clinically practical method to acquire parametric images of unidirectional metabolic rates and blood spaces."Journal of Nuclear Medicine, vol. 35, no. 7, p. 1206, 1994.
10. A. Dimitrakopoulou-Strauss, L. Strauss, M. Schwarzbach, C. Burger, T. Heichel, F. Willeke, G. Mechtersheimer, and T. Lehnert, "Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading," Journal of Nuclear Medicine, vol. 42, no. 5, pp. 713-720, 2001. (Pubitemid 32453458)
11. K. Zasadny and R. Wahl, "Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction." Radiology, vol. 189, no. 3, p. 847, 1993.
12. C. Kim, N. Gupta et al., "Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction." Nuclear medicine communications, vol. 17, no. 10, p. 890, 1996.
13. C. Kim, N. Gupta, B. Chandramouli, A. Alavi et al., "Standardized uptake values of FDG: body surface area correction is preferable to body weight correction." Journal of Nuclear Medicine, vol. 35, no. 1, p. 164, 1994.
14. L. Hamberg, G. Hunter, N. Alpert, N. Choi, J. Babich, and A. Fischman, "The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification?" Journal of Nuclear Medicine, vol. 35, no. 8, p. 1308, 1994.
15. J. Keyes Jr et al., "SUV: Standard uptake or silly useless value?" Journal of Nuclear Medicine, vol. 36, no. 10, p. 1836, 1995.
16. S. Huang, "Anatomy of SUV," Nuclear Medicine and Biology, vol. 27, no. 7, pp. 643-646, 2000.
17. M. Adams, T. Turkington, J. Wilson, and T. Wong, "A systematic review of the factors affecting accuracy of SUV measurements," American Journal of Roentgenology, vol. 195, no. 2, pp. 310-320, 2010.
18. W. Weber, S. Ziegler, R. Thödtmann, A. Hanauske, M. Schwaiger et al., "Reproducibility of metabolic measurements in malignant tumors using FDG PET. " Journal of Nuclear Medicine, vol. 40, no. 11, p. 1771, 1999.
19. S. Leskinen-Kallio, K. Någren, P. Lehikoinen, U. Ruotsalainen, M. Teräs, H. Joensuu et al., "Carbon-11-methionine and PET is an effective method to image head and neck cancer." Journal of Nuclear Medicine, vol. 33, no. 5, p. 691, 1992.
20. C. Patlak, R. Blasberg, J. Fenstermacher et al., "Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data," J Cereb Blood Flow Metab, vol. 3, no. 1, pp. 1-7, 1983. (Pubitemid 13129630)
21. A. Gjedde, "High-and low-affinity transport of D-glucose from blood to brain," Journal of Neurochemistry, vol. 36, no. 4, pp. 1463-1471, 1981. (Pubitemid 11070813)
22. Y. Zhou, W. Ye, J. Brasic, and D. Wong, "Multi-graphical analysis of dynamic PET," Neuroimage, vol. 49, no. 4, pp. 2947-2957, 2010.
23. C. Patlak and R. Blasberg, "Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. generalizations," Journal of Cerebral Blood Flow & Metabolism, vol. 5, no. 4, pp. 584-590, 1985. (Pubitemid 16218234)
24. C. Messa, Y. Choi, C. Hoh, E. Jacobs, J. Glaspy, S. Rege, E. Nitzsche, S. Huang, M. Phelps, R. Hawkins et al., "Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with pet." Journal of Computer Assisted Tomography, vol. 16, no. 5, p. 684, 1992.
25. A. Dimitrakopoulou-Strauss, V. Georgoulias, M. Eisenhut, F. Herth, S. Koukouraki, H. Mäcke, U. Haberkorn, and L. Strauss, "Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using 68 Ga-DOTATOC PET and comparison with 18 F-FDG PET," European journal of nuclear medicine and molecular imaging, vol. 33, no. 7, pp. 823-830, 2006. (Pubitemid 43979691)
26. S. Okazumi, A. Dimitrakopoulou-Strauss, M. Schwarzbach, and L. Strauss, "Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosis." Hellenic journal of Nuclear Medicine, vol. 12, no. 3, p. 223, 2009.
27. T. Torizuka, N. Tamaki, T. Inokuma, Y. Magata, S. Sasayama, Y. Yonekura, A. Tanaka, Y. Yamaoka, K. Yamamoto, j. Konishi et al., "In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. " Journal of Nuclear Medicine, vol. 36, no. 10, p. 1811, 1995.
28. Y. Sugawara, K. Zasadny, H. Grossman, I. Francis, M. Clarke, and R. Wahl, "Germ cell tumor: Differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling,"Radiology, vol. 211, no. 1, pp. 249-256, 1999. (Pubitemid 29161760)
29. A. Dimitrakopoulou-Strauss, L. Strauss, and C. Burger, "Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F] fluoro-L-dopa with 18F-FDG and I5O-water using compartment and noncompartment analysis," Journal of Nuclear Medicine, vol. 42, no. 2, pp. 248-256, 2001. (Pubitemid 32150515)
30. A. Dimitrakopoulou-Strauss, L. Strauss, C. Burger, A. Rühl, G. Irngartinger, W. Stremmel, and J. Rudi, "Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy," Journal of Nuclear Medicine, vol. 45, no. 9, pp. 1480-1487, 2004. (Pubitemid 47618501)
31. L. Strauss, o. Koczan, S. Klippel, L. Pan, C. Cheng, S. Willis, U. Haberkorn, and A. Dimitrakopoulou-Strauss, "Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors," Journal of Nuclear Medicine, vol. 49, no. 8, pp. 1238-1244, 2008.
32. L. Strauss, S. Klippel, L. Pan, K. Schönleben, U. Haberkorn, and A. Dimitrakopoulou-Strauss, "Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?" European journal of nuclear medicine and molecular imaging, vol. 34, no. 6, pp. 868-877, 2007. (Pubitemid 46798955)
33. H. Qiao, J. Bai, Y. Chen, and J. Tian, "Kidney modelling for FDG excretion with PET," International Journal of Biomedical Imaging, vol. 2007, pp. 632-634, 2007.
34. S. Jan, D. Benoit, E. Becheva, T. Carlier, F. Cassol, P. Descourt, T. Frisson, L. Grevillot, L. Guigues, L. Maigne et al., "GATE V6: a major enhancement of the GATE simulation platform enabling modelling of ct and radiotherapy," Physics in Medicine and Biology, vol. 56, p. 881, 2011.
35. W. Segars, G. Sturgeon, S. Mendonca, J. Grimes, and B. Tsui, "40 XCAT phantom for multimodality imaging research," Medical physics, vol. 37, p. 4902, 2010.
36. K. Thielemans, S. Mustafovic, and C. Tsoumpas, "STIR: software for tomographic image reconstruction release 2," in Nuclear Science Symposium Conference Record, 2006. IEEE, vol. 4. IEEE, 2006, pp. 2174-2176.